Orientation. Beyond the Ion Channel is where I try to make sense of pediatric neurogenetics in real time. It is a space to reflect on rare disease research, epilepsy genetics, synaptic disorders, and the scientific culture that surrounds them. I write as a clinician and researcher who spends most days in conversation with families, collaborators, advocates, trainees, and data.

The initial X-ray of DNA by Rosalind Franklin, which led to the suggestion that DNA might actually be a double helix (photo taken at King’s College, London in 2012).

Why this blog exists. In our field, discoveries accumulate quickly but meaning accumulates slowly. We publish papers, curate genes, analyze cohorts, and build models. Yet many of the most important questions remain interpretive. What does a new variant really tell us about a child sitting in clinic. When does a gene become a diagnosis. How do we move from statistical association to biological understanding. This blog exists to slow down that process and examine what we are actually learning.

What you will find here. Most posts are anchored in a recent study, often work that our group has contributed to. I focus on synaptic disorders, channelopathies, and developmental epilepsies, but I also write about broader themes such as biobanks, real world data, outcome measures, and the evolving language of rare disease research. I try to explain functional data, longitudinal phenotyping, medication response patterns, and gene curation frameworks in a way that connects molecular findings to lived experience.

A perspective from clinic and computation. My professional life sits at the intersection of pediatric neurology, human genetics, and computational analysis. In clinic, I meet families navigating uncertainty. In research, I work with large datasets, biobanks, and collaborative consortia. Beyond the Ion Channel reflects that dual perspective. It is as much about interpretation as it is about discovery.

On tone and approach. I write in the first person because science is not impersonal. Decisions about classification, evidence, and outcomes are made by people, often under conditions of incomplete information. I aim for a voice that is analytical but grounded, acknowledging both progress and limits. Rare disease research advances through accumulation, but it also requires judgment.

Beyond the Ion Channel. The title reflects a deliberate shift. Ion channels are central to many of the disorders we study, but the field has expanded to include synaptic proteins, transcriptional regulators, cytoskeletal scaffolds, and network level phenomena. Moving beyond the ion channel means broadening our conceptual frame without losing biological precision.

Who this is for. This blog is written for clinicians, researchers, trainees, industry partners, and families who want to understand how genetic discoveries translate into care. It is also for those interested in how evidence is built, challenged, and sometimes revised.

What you need to know. Beyond the Ion Channel is a reflective space grounded in clinical experience and data driven research in pediatric neurogenetics. I use recent studies, often from our own collaborative work, to examine how we interpret variants, define phenotypes, and measure outcomes in rare disease. The goal is not to simplify complexity, but to make it legible and actionable for a community working toward better understanding and better care.